Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial-Reference-Cited by-同舟云学术

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial

Published:2021-06 Issue:6 Volume:32 Page:746-756
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bardia A.,Messersmith W.A.,Kio E.A.,Berlin J.D.,Vahdat L.,Masters G.A.,Moroose R.,Santin A.D.,Kalinsky K.,Picozzi V.,O'Shaughnessy J.,Gray J.E.,Komiya T.,Lang J.M.,Chang J.C.,Starodub A.,Goldenberg D.M.,Sharkey R.M.,Maliakal P.,Hong Q.,Wegener W.A.,Goswami T.,Ocean A.J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference47 articles.

1. Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancer;Normann;J Gynecol Oncol,2019

2. Third- or later-line therapy for metastatic colorectal cancer: reviewing best practice;Bekaii-Saab;Clin Colorectal Cancer,2019

3. A review of systemic treatment in metastatic triple-negative breast cancer;Zeichner;Breast Cancer (Auckl),2016

4. Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents;Andre;Ann Oncol,2012

5. Advances in treatment and care in metastatic breast cancer (MBC): are there MBC patients who are curable?;Hattori;Chin Clin Oncol,2018

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma;Gynecologic Oncology;2024-10

2. Antibody-drug conjugates for hepato-pancreato-biliary malignancies: “Magic bullets” to the rescue?;Cancer Treatment Reviews;2024-09

3. Novel Antibody-Drug-Conjugates in Routine Clinical Practice for the Treatment of Metastatic Breast Cancer: Adherence, Efficacy and Tolerability – Real-World Data from German Breast Centers;Geburtshilfe und Frauenheilkunde;2024-09

4. Research progress of antibody–drug conjugates in gynecologic cancer;Holistic Integrative Oncology;2024-08-29

5. TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis;The Journal of Pathology: Clinical Research;2024-08-23